ADP ribosylation by PARP-1 suppresses HOXB7 transcriptional activity

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Wu, Xinyan ^a   Ellmann, Stephan ^a   Rubin, Ethel ^a   Gil, Minchan ^b   Jin, Kideok ^a   Han, Liangfeng ^a   Chen, Hexin ^a   Kwon, Erika M ^a   Guo, Jianhui ^b   Ha, Hyo Chol ^b   Sukumar, Saraswati ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; GLUTAMIC ACID; HOX PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN HOXA7; PROTEIN HOXB7; UNCLASSIFIED DRUG;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CATALYSIS; CELL CULTURE; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSFECTION; MUTANT; PLASMID; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM;

ADENOSINE DIPHOSPHATE RIBOSE; ANIMALS; BIOCATALYSIS; CELL LINE; DNA; GLUTAMIC ACID; HOMEODOMAIN PROTEINS; HUMANS; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN STRUCTURE, TERTIARY; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; ZINC FINGERS;

EID: 84864204720     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040644     Document Type: Article

References (46)

1. Krumlauf R, (1994) Hox genes in vertebrate development. Cell 78: 191-201.
2. Abate-Shen C, (2002) Deregulated homeobox gene expression in cancer: cause or consequence? Nat Rev Cancer 2: 777-785.
3. Iwasaki M, Kuwata T, Yamazaki Y, Jenkins NA, Copeland NG, et al. (2005) Identification of cooperative genes for NUP98-HOXA9 in myeloid leukemogenesis using a mouse model. Blood 105: 784-793.
4. Kroon E, Krosl J, Thorsteinsdottir U, Baban S, Buchberg AM, et al. (1998) Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J 17: 3714-3725.
5. Wu X, Chen H, Parker B, Rubin E, Zhu T, et al. (2006) HOXB7, a homeodomain protein, is overexpressed in breast cancer and confers epithelial-mesenchymal transition. Cancer Res 66: 9527-9534.
6. Ma XJ, Hilsenbeck SG, Wang W, Ding L, Sgroi DC, et al. (2006) The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer. J Clin Oncol 24: 4611-4619.
7. Ma XJ, Wang Z, Ryan PD, Isakoff SJ, Barmettler A, et al. (2004) A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell 5: 607-616.
8. Chen H, Chung S, Sukumar S, (2004) HOXA5-induced apoptosis in breast cancer cells is mediated by caspases 2 and 8. Mol Cell Biol 24: 924-935.
9. Raman V, Martensen SA, Reisman D, Evron E, Odenwald WF, et al. (2000) Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature 405: 974-978.
10. Mann RS, Affolter M, (1998) Hox proteins meet more partners. Curr Opin Genet Dev 8: 423-429.
11. Lu Q, Kamps MP, (1997) Heterodimerization of Hox proteins with Pbx1 and oncoprotein E2a-Pbx1 generates unique DNA-binding specifities at nucleotides predicted to contact the N-terminal arm of the Hox homeodomain-demonstration of Hox-dependent targeting of E2a-Pbx1 in vivo. Oncogene 14: 75-83.
12. Chang CP, Shen WF, Rozenfeld S, Lawrence HJ, Largman C, et al. (1995) Pbx proteins display hexapeptide-dependent cooperative DNA binding with a subset of Hox proteins. Genes Dev 9: 663-674.
13. Lu Q, Knoepfler PS, Scheele J, Wright DD, Kamps MP, (1995) Both Pbx1 and E2A-Pbx1 bind the DNA motif ATCAATCAA cooperatively with the products of multiple murine Hox genes, some of which are themselves oncogenes. Mol Cell Biol 15: 3786-3795.
14. Shen WF, Krishnan K, Lawrence HJ, Largman C, (2001) The HOX homeodomain proteins block CBP histone acetyltransferase activity. Mol Cell Biol 21: 7509-7522.
15. Li X, Nie S, Chang C, Qiu T, Cao X, (2006) Smads oppose Hox transcriptional activities. Exp Cell Res 312: 854-864.
16. Williams TM, Williams ME, Heaton JH, Gelehrter TD, Innis JW, (2005) Group 13 HOX proteins interact with the MH2 domain of R-Smads and modulate Smad transcriptional activation functions independent of HOX DNA-binding capability. Nucleic Acids Res 33: 4475-4484.
17. Rubin E, Wu X, Zhu T, Cheung JC, Chen H, et al. (2007) A role for the HOXB7 homeodomain protein in DNA repair. Cancer Res 67: 1527-1535.
18. Jagtap P, Szabo C, (2005) Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat Rev Drug Discov 4: 421-440.
19. Kim MY, Zhang T, Kraus WL, (2005) Poly(ADP-ribosyl)ation by PARP-1: 'PAR-laying' NAD+ into a nuclear signal. Genes Dev 19: 1951-1967.
20. Cervellera MN, Sala A, (2000) Poly(ADP-ribose) polymerase is a B-MYB coactivator. J Biol Chem 275: 10692-10696.
21. Santilli G, Cervellera MN, Johnson TK, Lewis RE, Iacobelli S, et al. (2001) PARP co-activates B-MYB through enhanced phosphorylation at cyclin/cdk2 sites. Oncogene 20: 8167-8174.
22. Anderson MG, Scoggin KE, Simbulan-Rosenthal CM, Steadman JA, (2000) Identification of poly(ADP-ribose) polymerase as a transcriptional coactivator of the human T-cell leukemia virus type 1 Tax protein. J Virol 74: 2169-2177.
23. Elser M, Borsig L, Hassa PO, Erener S, Messner S, et al. (2008) Poly(ADP-ribose) polymerase 1 promotes tumor cell survival by coactivating hypoxia-inducible factor-1-dependent gene expression. Mol Cancer Res 6: 282-290.
24. Oei SL, Griesenbeck J, Schweiger M, Babich V, Kropotov A, et al. (1997) Interaction of the transcription factor YY1 with human poly(ADP-ribosyl) transferase. Biochem Biophys Res Commun 240: 108-111.
25. Butler AJ, Ordahl CP, (1999) Poly(ADP-ribose) polymerase binds with transcription enhancer factor 1 to MCAT1 elements to regulate muscle-specific transcription. Mol Cell Biol 19: 296-306.
26. Ju BG, Lunyak VV, Perissi V, Garcia-Bassets I, Rose DW, et al. (2006) A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription. Science 312: 1798-1802.
27. Nirodi C, NagDas S, Gygi SP, Olson G, Aebersold R, et al. (2001) A role for poly(ADP-ribose) polymerase in the transcriptional regulation of the melanoma growth stimulatory activity (CXCL1) gene expression. J Biol Chem 276: 9366-9374.
28. Pavri R, Lewis B, Kim TK, Dilworth FJ, Erdjument-Bromage H, et al. (2005) PARP-1 determines specificity in a retinoid signaling pathway via direct modulation of mediator. Mol Cell 18: 83-96.
29. Kraus WL, Lis JT, (2003) PARP goes transcription. Cell 113: 677-683.
30. Yaron Y, McAdara JK, Lynch M, Hughes E, Gasson JC, (2001) Identification of novel functional regions important for the activity of HOXB7 in mammalian cells. J Immunol 166: 5058-5067.
31. Li Y, Oh HJ, Lau YF, (2006) The poly(ADP-ribose) polymerase 1 interacts with Sry and modulates its biological functions. Mol Cell Endocrinol 257-258: 35-46.
32. Chen H, Rubin E, Zhang H, Chung S, Jie CC, et al. (2005) Identification of transcriptional targets of HOXA5. J Biol Chem 280: 19373-19380.
33. Marsischky GT, Wilson BA, Collier RJ, (1995) Role of glutamic acid 988 of human poly-ADP-ribose polymerase in polymer formation. Evidence for active site similarities to the ADP-ribosylating toxins. J Biol Chem 270: 3247-3254.
34. Chen H, Sukumar S, (2003) HOX genes: emerging stars in cancer. Cancer Biol Ther 2: 524-525.
35. Cohen-Armon M, Visochek L, Rozensal D, Kalal A, Geistrikh I, et al. (2007) DNA-independent PARP-1 activation by phosphorylated ERK2 increases Elk1 activity: a link to histone acetylation. Molecular cell 25: 297-308.
36. Chariot A, Princen F, Gielen J, Merville MP, Franzoso G, et al. (1999) IkappaB-alpha enhances transactivation by the HOXB7 homeodomain-containing protein. J Biol Chem 274: 5318-5325.
37. Chariot A, van Lint C, Chapelier M, Gielen J, Merville MP, et al. (1999) CBP and histone deacetylase inhibition enhance the transactivation potential of the HOXB7 homeodomain-containing protein. Oncogene 18: 4007-4014.
38. Knoepfler PS, Kamps MP, (1995) The pentapeptide motif of Hox proteins is required for cooperative DNA binding with Pbx1, physically contacts Pbx1, and enhances DNA binding by Pbx1. Mol Cell Biol 15: 5811-5819.
39. Simbulan-Rosenthal CM, Rosenthal DS, Luo R, Samara R, Espinoza LA, et al. (2003) PARP-1 binds E2F-1 independently of its DNA binding and catalytic domains, and acts as a novel coactivator of E2F-1-mediated transcription during re-entry of quiescent cells into S phase. Oncogene 22: 8460-8471.
40. Chang CP, Shen WF, Rozenfeld S, Lawrence HJ, Largman C, et al. (1995) Pbx proteins display hexapeptide-dependent cooperative DNA binding with a subset of Hox proteins. Genes & development 9: 663-674.
41. Stern S, Tanaka M, Herr W, (1989) The Oct-1 homoeodomain directs formation of a multiprotein-DNA complex with the HSV transactivator VP16. Nature 341: 624-630.
42. Suzuki T, Nishi T, Nagino T, Sasaki K, Aizawa K, et al. (2007) Functional interaction between the transcription factor Kruppel-like factor 5 and poly(ADP-ribose) polymerase-1 in cardiovascular apoptosis. J Biol Chem 282: 9895-9901.
43. Li M, Naidu P, Yu Y, Berger NA, Kannan P, (2004) Dual regulation of AP-2alpha transcriptional activation by poly(ADP-ribose) polymerase-1. Biochem J 382: 323-329.
44. Zhang X, Zhu T, Chen Y, Mertani HC, Lee KO, et al. (2003) Human growth hormone-regulated HOXA1 is a human mammary epithelial oncogene. J Biol Chem 278: 7580-7590.
45. Ha HC, Hester LD, Snyder SH, (2002) Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia. Proc Natl Acad Sci U S A 99: 3270-3275.
46. Zhang S, Fei T, Zhang L, Zhang R, Chen F, et al. (2007) Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation. Mol Cell Biol 27: 4488-4499.